Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
If you live in the Kuliouou-Kalani Iki area of Honolulu, Hawaii, Made Peptide brings fully personalized peptide therapy directly to your door. Honolulu County residents receive a physician-designed custom plan — not a one-size-fits-all prescription. Your physician evaluates your individual health profile and builds a dosing schedule calibrated specifically for your body.
Peptide medications — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are prescribed by HI-licensed doctors via telehealth and delivered to your Honolulu home. Your custom plan ensures optimal dosing for residents of Kuliouou-Kalani Iki and surrounding Honolulu County neighborhoods.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 4, 2026
Ozempic (diabetes) and Wegovy (weight loss). Personalized 16-20 week titration to therapeutic dose — custom-designed for your body using the evidence from the STEP clinical trials.
Mounjaro (diabetes) and Zepbound (weight loss). Dual GLP-1/GIP personalized plan — custom 20-week titration designed for your individual metabolic profile.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to Kuliouou-Kalani Iki, Honolulu residents:
Telehealth prescribing of GLP-1 receptor agonists in Hawaii is conducted by board-certified, HI-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Your custom peptide plan in Kuliouou-Kalani Iki is built around your body — a physician-supervised, personalized process from assessment through active treatment. Every phase is designed to maximize your individual results.
Complete a detailed health questionnaire from your home in Kuliouou-Kalani Iki. It covers your weight history, metabolic health, current medications, and goals — giving your physician everything needed to build a custom peptide plan calibrated for your specific body.
A HI-licensed physician reviews your assessment and conducts a telehealth consultation. They select the appropriate peptide agent, establish your personalized titration schedule, and outline what to expect at each plan milestone. You begin with a roadmap built for your body.
Your peptide medication ships from a licensed US pharmacy to your Kuliouou-Kalani Iki address within 3-5 business days. Your custom plan begins immediately — with scheduled physician check-ins at each dose milestone to monitor your individual progress and update your plan as needed.
Personalized peptide weight loss plans serve all neighborhoods in Honolulu and the surrounding area.
Custom peptide plans are available throughout Honolulu, HI — personalized therapy in every neighborhood.
Personalized peptide therapy plans are available in cities near Honolulu through our licensed physician network.
Personalized peptide therapy is available in the largest cities across Hawaii.
Personalized peptide therapy is available nationwide. Find your city and build your custom plan.
Local weight loss and GLP-1 providers serving the Kuliouou-Kalani Iki, Honolulu, HI area, based on Google Business listings.
850 W Hind Dr Ste 109, Honolulu, HI 96821
4.7/5 ★ (15 reviews)
5/5 ★ (12 reviews)
1441 Kapiolani Blvd Suite 1002
4.5/5 ★ (4 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
A custom peptide plan for Kuliouou-Kalani Iki residents is a physician-designed, personalized approach to peptide weight loss therapy. It begins with a comprehensive health assessment, selects the appropriate FDA-approved peptide medication (semaglutide, tirzepatide, or liraglutide), and builds a dosing schedule calibrated specifically for your body — monitored by a HI-licensed physician through regular telehealth check-ins.
All peptide medications prescribed in your custom plan ship from licensed US pharmacies directly to your Kuliouou-Kalani Iki home. Delivery to Honolulu County typically takes 3-5 business days. Your medication arrives with personalized dosing instructions from your physician — no pharmacy visits required.
Patients on custom peptide plans achieve 15% average weight reduction with semaglutide and up to 22% with tirzepatide over 68-72 weeks, based on clinical trial data. Most Kuliouou-Kalani Iki plan patients begin noticing appetite reduction within the first 2 weeks and measurable weight loss by week 8.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
